Effect of angiotensin converting enzyme gene I/D polymorphism and its expression on clinical outcome in acute respiratory distress syndrome

Minerva Anestesiologica

Volumn 79, Issue 8, 2013, Pages 861-870

  Tsantes, A E ^a   Kopterides, P ^a   Bonovas, S ^b,c,d   Bagos, P ^c   Antonakos, G ^a   Nikolopoulos, G K ^b,e   Gialeraki, A ^a   Kapsimali, V ^d   Kyriakou, E ^a   Kokori, S ^a   Dima, K ^a   Armaganidis, A ^a   Tsangaris, I ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b Hellenic Centre for Disease Control and Prevention   (Greece)

^c UNIVERSITY OF CENTRAL GREECE   (Greece)

^d UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^e NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

Author keywords

Angiotensin converting enzyme inhibitors; Polymorphism, genetic; Respiratory distress syndrome, adult

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; PREDNISOLONE;

ACUTE LUNG INJURY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LACTATE BLOOD LEVEL; LUNG COMPLIANCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PROGNOSIS; VENTILATED PATIENT;

ADULT; AGED; AGED, 80 AND OVER; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY FUNCTION TESTS; RISK FACTORS;

EID: 84886088886     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Hudson LD, Milberg JA, Anardi D, Maunder RJ. Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995;151:293-301.
2. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000;342:1334-49.
3. Yamamoto T, Wang L, Shimakura K, Sanaka M, Koike Y, Mineshita S. Angiotensin II-induced pulmonary edema in a rabbit model. Jpn J Pharmacol 1997;73:33-40. (Pubitemid 27078008)
4. Kiely DG, Cargill RI, Wheeldon NM, Coutie WJ, Lipworth BJ. Haemodynamic and endocrine effects of type 1 angiotensin II receptor blockade in patients with hypoxaemic cor pulmonale. Cardiovasc Res 1997;33:201-8. (Pubitemid 27019116)
5. Marshall RP, Puddicombe A, Cookson WO, Laurent GJ. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax 2000;55:143-6. (Pubitemid 30245956)
6. Fourrier F, Chopin C, Wallaert B, Mazurier C, Mangalaboyi J, Durocher A. Compared evolution of plasma fibronectin and angiotensin-converting enzyme levels in septic ARDS. Chest 1985;87:191-5. (Pubitemid 15174050)
7. Liu YH, Yang XP, Mehta D, Bulagannawar M, Scicli GM, Carretero OA. Role of kinins in chronic heart failure and in the therapeutic effect of ACE inhibitors in kininogen-deficient rats. Am J Physiol Heart Circ Physiol 2000;278:507-14.
8. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6. (Pubitemid 20370444)
9. Idell S, Kueppers F, Lippmann M, Rosen H, Niederman M, Fein A. Angiotensin converting enzyme in bronchoalveolar lavage in ARDS. Chest 1987;91:52-6. (Pubitemid 17215792)
10. Jerng JS, Yu CJ, Wang HC, Chen KY, Cheng SL, Yang PC. Polymorphism of the angiotensin-converting enzyme gene affects the outcome of acute respiratory distress syndrome. Crit Care Med 2006;34:1001-6.
11. Adamzik M, Frey U, Sixt S, Knemeyer L, Beiderlinden M, Peters J et al. ACE I/D but not AGT (-6)A/G polymorphism is a risk factor for mortality in ARDS. Eur Respir J 2007;29:482-8. (Pubitemid 46372094)
12. Villar J, Flores C, Perez-Mendez L, Maca-Meyer N, Espinosa E, Blanco J et al. Angiotensin-converting enzyme insertion/deletion polymorphism is not associated with susceptibility and outcome in sepsis and acute respiratory distress syndrome. Intensive Care Med 2008;34:488-95. (Pubitemid 351623027)
13. Fourrier F, Chopin C, Wallaert B, Mazurier C, Mangalaboyi J, Durocher A. Compared evolution of plasma fibronectin and angiotensin-converting enzyme levels in septic ARDS. Chest 1985;87:191-5. (Pubitemid 15174050)
14. Tsangaris I, Tsantes A, Bagos P, Nikolopoulos G, Kroupis C, Kopterides P et al. The effect of plasma homocysteine levels on clinical outcomes of patients with ALI/ARDS. Am J Med Sci 2009;338:474-7.
15. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L et al. "The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-24. (Pubitemid 24082248)
16. Ferguson ND, Fan E, Camporota L, Antonelli M, Anzueto A, Beale R et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med 2012;38:1573-82.
17. Tsantes A, Tsangaris I, Kopterides P, Nikolopoulos G, Kalamara E, Antonakos G et al. Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism and circulating ACE levels are not associated with outcome in critically ill septic patients. Clin Chem Lab Med 2011;50:293-9.
18. Tsangaris I, Tsantes A, Bonovas S, Duffy CM. The impact of the PAI-1 4G/5G polymorphism on the outcome of patients with ALI/ARDS. Thromb Research 2009;123:832-6.
19. Collet D. Modelling survival data in medical research. London: Chapman & Hall; 1994.
20. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-12. (Pubitemid 30214957)
21. Bagos PG. A unification of multivariate methods for meta-analysis of genetic association studies. Stat Appl Genet Mol Biol 2008;7:Article 13.
22. Jackson D, White IR, Thompson SG. Extending DerSimonian and Lairds methodology to perform multivariate random effects meta-analyses. Stat Med 2010;29:1282-97.
23. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7:177-88. (Pubitemid 17189972)
24. Petitti DB. Meta-analysis, decision analysis, and cost-effectiveness analysis. New York: Oxford University Press; 2000.
25. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60. (Pubitemid 37088507)
26. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101.
27. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34. (Pubitemid 27387172)
28. Bagos PG, Nikolopoulos GK. Generalized least squares for assessing trends in cumulative meta-analysis with applications in genetic epidemiology. J Clin Epidemiol 2009;62:1037-44.
29. Cruces P, Díaz F, Puga A, Erranz B, Donoso A, Carvajal C et al. Angiotensin-converting enzyme insertion/deletion polymorphism is associated with severe hypoxemia in pediatric ARDS. Intensive Care Med 2012; 38:113-9.
30. Marshall RP, Webb S, Bellingan GJ, Montgomery HE, Chaudhari B, McAnulty RJ et al. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med 2002;166:646-50. (Pubitemid 34971844)
31. Lu XM, Chen GJ, Yang Y, Qiu HB. Angiotensin- converting enzyme polymorphism affects outcome of local Chinese with acute lung injury. Respiratory Medicine 2011;105:1485-90.
32. Guazzi M, Melzi G, Marenzi GC, Agostoni P. Angiotensin-converting enzyme inhibition facilitates alveolar-capillary gas transfer and improves ventilation-perfusion- coupling in patients with left ventricular dysfunction. Clin Pharmacol Ther 1999;65:319-27. (Pubitemid 29142938)
33. Suzuki M, Teramoto S, Katayama H, Ohga E, Matsuse T, Ouchi Y. Effects of angiorensin-converting enzyme (ACE) inhibitors on oxygen radical production and generation by murine lung alveolar macrophages. J Asthma 1999:36:665-70. (Pubitemid 30012841)
34. Casey L, Krieger B, Kohler J, Rice C, Oparil S, Szidon P. Decreased serum angiotensin converting enzyme in adult respiratory distress syndrome associated with sepsis: a preliminary report. Crit Care Med 1981;9:651-4.
35. Fourrier F, Chopin C, Wallaert B, Wattre P, Mangalaboyi J, Durocher A et al. Angiotensin-converting enzyme in human ARDS. Chest 1983;83:593-7.
36. Fishel RS, Eisenberg S, Shai SY, Redden RA, Bernstein KE, Berk BC. Glucocorticoids induce angiotensin-converting enzyme expression in vascular smooth muscle. Hypertension 1995;25:343-9.
37. Zhao X, White R, Huang BS, Van Huysse J, Leenen FH. High salt intake and the brain rennin-angiotensin system in Dahl salt-sensitive rats. J Hypertens 2001;19:89-98. (Pubitemid 32099280)
38. Zilberberg MD, Epstein SK. Acute lung injury in the medical ICU: comorbid conditions, age, etiology and hospital outcome. Am J Respir Crit Care Med 1998; 157:1159-64.
39. Doyle RL, Szaflarski N, Modin GW, Wiener-Kronish JP, Matthay MA. Identification of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care Med 1995;152:1818-24.
40. Clinicaltrials.gov. The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury [Internet} [[cited 2013 June 28], Available at: http://www.clinicaltrials.gov/ct2/show/NCT01597635?term=ARDS&rank=133